Hpc Biosciences Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 04-07-2024
- Paid Up Capital ₹ 15.96 Cr
as on 04-07-2024
- Company Age 22 Year, 9 Months
- Last Filing with ROC 31 Mar 2021
- Revenue 82.20%
(FY 2021)
- Profit 247.42%
(FY 2021)
- Ebitda 86.77%
(FY 2021)
- Net Worth 3.69%
(FY 2021)
- Total Assets 3.09%
(FY 2021)
About Hpc Biosciences
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 535217.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 15.96 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mumataj, Radha Kumari, Kishori Gupta, and One other member serve as directors at the Company.
- CIN/LLPIN
L24119DL2002PLC114026
- Company No.
114026
- Stock Symbol
BSE : 535217
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
29 Jan 2002
- Date of AGM
22 Sep 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Listed
- ROC Code
Roc Delhi
Industry
Company Details
- Location
East Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Hpc Biosciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mumataj  | Director | 03-Mar-2016 | Current |
| Radha Kumari | Additional Director | 05-Sep-2022 | Current |
| Kishori Gupta | Director | 13-Mar-2018 | Current |
| Chandan Mandal | Additional Director | 05-Sep-2022 | Current |
Financial Performance and Corporate Structure Insights of Hpc Biosciences.
Hpc Biosciences Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 82.2% increase. The company also saw a substantial improvement in profitability, with a 247.42% increase in profit. The company's net worth moved up by a moderate rise of 3.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hpc Biosciences?
In 2021, Hpc Biosciences had a promoter holding of 21.93% and a public holding of 78.08%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hpc Biosciences?
Unlock and access historical data on people associated with Hpc Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hpc Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hpc Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
